Combined Synopsis/Solicitation - Requirement is to analyze the human urine specimens for anabolic steroids.

This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR 12.6, Streamlined Procedures for Evaluation and Solicitation of Commercial Items, FAR 13 Simplified Acquisition Procedures, FAR 13.5 Test Program for Certain Commercial Items, and FAR 16.503 Requirements Contracts, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. It is the contractor’s responsibility to be familiar with the applicable FAR and DFARS clauses and provisions. The FAR and DFARS clauses may be accessed in full text at these addresses: https://www.acquisition.gov/FAR/ and www.acq.osd.mil/dpap/dfars/index.htm.





The NAICS code is 541380, with a business size standard of $14 M.



This Request for Proposal (RFP) is on behalf of the Department of Defense (DOD) Drug Demand Reduction Program (DDRP) Laboratories. This requirement is for Steroid Testing Services for the detection of steroid abuse in urine and telephonic consultation.



The solicitation number is N62645-13-R-0027-0001. (This is the original solicitation).



This solicitation will result in one firm fixed price Requirements type contract with a five year period of performance. Period of Performance shall be from 01 June 2013 – 31 May 2018. The requirement will be fulfilled via an unrestricted, full and open competitive acquisition.



Proposal Submission

Proposals are due by 13 May 2013 by 04:00 PM Local Time.

Proposals shall be submitted in accordance with the Instructions to Offeror of this request to Amanda.Rutten@med.navy.mil, (subject: N62645-13-R-0027 Steroid Testing Services).